You are here: Industry Insights > Pfizer

News List

Concerto HealthAI collaborates with Pfizer for precision oncology biospectrumasia
April 11, 2019
A Concerto HealthAI-Pfizer joint steering committee will oversee the collaboration. The first outcomes research and publications are expected in early 2020.
Sangamo, Pfizer Announce Phase 1/2 Interim Data for Investigational Hemophilia A Gene Therapy americanpharmaceuticalreview
April 11, 2019
Sangamo, Pfizer Announce Phase 1/2 Interim Data for Investigational Hemophilia A Gene Therapy.
FDA approves Pfizer's Ibrance for advanced male breast cancer pharmafile
April 11, 2019
FDA approves Pfizer's Ibrance for advanced male breast cancer.
England's NICE rebuffs Pfizer and Astellas' Xtandi in nonmetastatic prostate cancer fiercepharma
April 09, 2019
Pfizer and Astellas’ Xtandi is looking for a leg up on prostate cancer rival Erleada from J&J. But it won't be getting it in England.
Pfizer uses real-world data to score Ibrance breast cancer nod in males fiercepharma
April 08, 2019
Breast cancer is a rare disease in men, making it tough for drugmakers to conduct clinical trials. But Pfizer came up with a solution.
Pfizer, Sangamo report positive early-stage data for gene therapy SB-525 in haemophilia A firstwordpharma
April 02, 2019
Pfizer and Sangamo Therapeutics on Tuesday reported that two patients with severe haemophilia A……
Pfizer, Merck KGaA scrap yet another Bavencio ovarian cancer trial fiercepharma
March 21, 2019
Pfizer and Merck KGaA have had a rough go at broadening immuno-oncology drug Bavencio's reach……
BMS, Pfizer's Eliquis tops warfarin in high-risk afib subgroup fiercepharma
March 19, 2019
Pfizer and Bristol-Myers Squibb’s next-gen anticoagulant Eliquis has been stealing warfarin market share for years, but that doesn't mean it's slowing down.
Ex-Pfizer CEO Ian Read sees 2018 pay slashed by a third as incentive package plummets fiercepharma
March 18, 2019
In 2017, Pfizer’s board of directors was throwing money at CEO Ian Read to persuade him to stay at least through March of this year. His total compensation jumped more than 60% to $27.9 million, though a lot of that came from equity-based incentives.
Pfizer plant that is closing gets farewell warning letter from FDA fiercepharma
March 15, 2019
Last year, Pfizer stopped manufacturing and recalled products from a Hospira sterile injectables plant in India that the FDA has repeatedly criticized. It recently announced it would close the plant.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 83 84 Next page